Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the <scp>IIISAS</scp> randomised trial

Anette B. Kvaslerud, Sara Bardan, Kristoffer Andresen, Sophie F. Kløve, Morten W. Fagerland, Thor Edvardsen, Lars Gullestad, Kaspar Broch

Open source

DOI
10.1002/ejhf.2557
Published
2022-06-03
Container
European Journal of Heart Failure
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ejhf.2557,
  title = {Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the
                    <scp>IIISAS</scp>
                    randomised trial},
  author = {Anette B. Kvaslerud and Sara Bardan and Kristoffer Andresen and Sophie F. Kløve and Morten W. Fagerland and Thor Edvardsen and Lars Gullestad and Kaspar Broch},
  year = {2022},
  journal = {European Journal of Heart Failure},
  doi = {10.1002/ejhf.2557},
  url = {https://doi.org/10.1002/ejhf.2557}
}

RIS

TY  - JOUR
TI  - Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the
                    <scp>IIISAS</scp>
                    randomised trial
AU  - Anette B. Kvaslerud
AU  - Sara Bardan
AU  - Kristoffer Andresen
AU  - Sophie F. Kløve
AU  - Morten W. Fagerland
AU  - Thor Edvardsen
AU  - Lars Gullestad
AU  - Kaspar Broch
PY  - 2022
JO  - European Journal of Heart Failure
DO  - 10.1002/ejhf.2557
UR  - https://doi.org/10.1002/ejhf.2557
ER  - 

APA

Kvaslerud, A. B., Bardan, S., Andresen, K., Kløve, S. F., Fagerland, M. W., Edvardsen, T., Gullestad, L., & Broch, K. (2022). Intravenous iron supplement for iron deficiency in patients with severe aortic stenosis scheduled for transcatheter aortic valve implantation: results of the <scp>IIISAS</scp> randomised trial. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.2557

Source records